The Impact of COVID-19 is included in Alzheimer's Disease Diagnostic Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
AlzheimerÄX%$%Xs Disease Trends and Forecast
The future of the global alzheimerÄX%$%Xs disease diagnostic market looks promising with opportunities in the clinic, hospital, diagnostic center, pharmaceutical company, and academic research center markets. The global alzheimerÄX%$%Xs disease diagnostic market is expected to reach an estimated $5.4 billion by 2030 with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are increasing prevalence of alzheimerÄX%$%Xs disease, rising demand for early diagnosis, and rapid advancement in healthcare technology.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
AlzheimerÄX%$%Xs Disease by Segment
The study includes a forecast for the global alzheimerÄX%$%Xs disease by type, end use, and region.
AlzheimerÄX%$%Xs Disease Diagnostic Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Nervous System
• Examination
• Genetic Testing
• Minor Mental State Examination
• Brain Imaging Tests
AlzheimerÄX%$%Xs Disease Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Clinics
• Hospitals
• Diagnostic Centers
• Pharmaceutical Companies
• Academic Research Centers
AlzheimerÄX%$%Xs Disease Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of AlzheimerÄX%$%Xs Disease Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies alzheimerÄX%$%Xs disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the alzheimerÄX%$%Xs disease companies profiled in this report include-
• AbbVie
• AC Immune
• Amarantus Bioscience
• Anavex Life Sciences
• Eli Lilly And Company
• AXON Neuroscience
• Sio Gene Therapies
AlzheimerÄX%$%Xs Disease Diagnostic Market Insights
Lucintel forecasts that brain imaging test is expected to witness highest growth over the forecast period.
North America is expected to witness highest growth over the forecast period due to high prevalence of alzheimerÄX%$%Xs disease and rapid adoption of new diagnostic technologies in the region.
Features of the Global AlzheimerÄX%$%Xs Disease Diagnostic Market
Market Size Estimates: AlzheimerÄX%$%Xs disease diagnostic market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: AlzheimerÄX%$%Xs disease diagnostic market size by type, end use, and region in terms of value ($B).
Regional Analysis: AlzheimerÄX%$%Xs disease diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the alzheimerÄX%$%Xs disease diagnostic market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the alzheimerÄX%$%Xs disease diagnostic market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the alzheimerÄX%$%Xs disease diagnostic market size?
Answer: The global alzheimerÄX%$%Xs disease diagnostic market is expected to reach an estimated $5.4 billion by 2030.
Q.2 What is the growth forecast for alzheimerÄX%$%Xs disease diagnostic market?
Answer: The global alzheimerÄX%$%Xs disease diagnostic market is expected to grow with a CAGR of 7.8% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the alzheimerÄX%$%Xs disease diagnostic market?
Answer: The major drivers for this market are increasing prevalence of alzheimerÄX%$%Xs disease, rising demand for early diagnosis, and rapid advancement in healthcare technology.
Q4. What are the major segments for alzheimerÄX%$%Xs disease diagnostic market?
Answer: The future of the alzheimerÄX%$%Xs disease diagnostic market looks promising with opportunities in the clinic, hospital, diagnostic center, pharmaceutical company, and academic research center markets.
Q5. Who are the key alzheimerÄX%$%Xs disease diagnostic market companies?
Answer: Some of the key alzheimerÄX%$%Xs disease companies are as follows:
• AbbVie
• AC Immune
• Amarantus Bioscience
• Anavex Life Sciences
• Eli Lilly And Company
• AXON Neuroscience
• Sio Gene Therapies
Q6. Which alzheimerÄX%$%Xs disease diagnostic market segment will be the largest in future?
Answer: Lucintel forecasts that brain imaging test is expected to witness highest growth over the forecast period.
Q7. In alzheimerÄX%$%Xs disease diagnostic market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to high prevalence of alzheimerÄX%$%Xs disease and rapid adoption of new diagnostic technologies in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the alzheimerÄX%$%Xs disease diagnostic market by type (nervous system, examination, genetic testing, minor mental state examination, and brain imaging tests), end use (clinics, hospitals, diagnostic centers, pharmaceutical companies, and academic research centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to AlzheimerÄX%$%XS Disease Market, AlzheimerÄX%$%XS Disease Market Size, AlzheimerÄX%$%XS Disease Market Growth, AlzheimerÄX%$%XS Disease Market Analysis, AlzheimerÄX%$%XS Disease Market Report, AlzheimerÄX%$%XS Disease Market Share, AlzheimerÄX%$%XS Disease Market Trends, AlzheimerÄX%$%XS Disease Market Forecast, AlzheimerÄX%$%XS Disease Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global AlzheimerÄX%$%Xs Disease Diagnostic Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global AlzheimerÄX%$%Xs Disease Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global AlzheimerÄX%$%Xs Disease Diagnostic Market by Type
3.3.1: Nervous System
3.3.2: Examination
3.3.3: Genetic Testing
3.3.4: Minor Mental State Examination
3.3.5: Brain Imaging Tests
3.4: Global AlzheimerÄX%$%Xs Disease Diagnostic Market by End Use
3.4.1: Clinics
3.4.2: Hospitals
3.4.3: Diagnostic Centers
3.4.4: Pharmaceutical Companies
3.4.5: Academic Research Centers
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global AlzheimerÄX%$%Xs Disease Diagnostic Market by Region
4.2: North American AlzheimerÄX%$%Xs Disease Diagnostic Market
4.2.2: North American AlzheimerÄX%$%Xs Disease Diagnostic Market by End Use: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, and Academic Research Centers
4.3: European AlzheimerÄX%$%Xs Disease Diagnostic Market
4.3.1: European AlzheimerÄX%$%Xs Disease Diagnostic Market by Type: Nervous System, Examination, Genetic Testing, Minor Mental State Examination, and Brain Imaging Tests
4.3.2: European AlzheimerÄX%$%Xs Disease Diagnostic Market by End Use: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, and Academic Research Centers
4.4: APAC AlzheimerÄX%$%Xs Disease Diagnostic Market
4.4.1: APAC AlzheimerÄX%$%Xs Disease Diagnostic Market by Type: Nervous System, Examination, Genetic Testing, Minor Mental State Examination, and Brain Imaging Tests
4.4.2: APAC AlzheimerÄX%$%Xs Disease Diagnostic Market by End Use: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, and Academic Research Centers
4.5: ROW AlzheimerÄX%$%Xs Disease Diagnostic Market
4.5.1: ROW AlzheimerÄX%$%Xs Disease Diagnostic Market by Type: Nervous System, Examination, Genetic Testing, Minor Mental State Examination, and Brain Imaging Tests
4.5.2: ROW AlzheimerÄX%$%Xs Disease Diagnostic Market by End Use: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, and Academic Research Centers
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global AlzheimerÄX%$%Xs Disease Diagnostic Market by Type
6.1.2: Growth Opportunities for the Global AlzheimerÄX%$%Xs Disease Diagnostic Market by End Use
6.1.3: Growth Opportunities for the Global AlzheimerÄX%$%Xs Disease Diagnostic Market by Region
6.2: Emerging Trends in the Global AlzheimerÄX%$%Xs Disease Diagnostic Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global AlzheimerÄX%$%Xs Disease Diagnostic Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global AlzheimerÄX%$%Xs Disease Diagnostic Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: AbbVie
7.2: AC Immune
7.3: AMARANTUS BIOSCIENCE
7.4: Anavex Life Sciences
7.5: Eli Lilly and Company
7.6: AXON Neuroscience
7.7: Sio Gene Therapies
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Alzheimer's Disease Diagnostic Market Report.